The Yoshinori Yoshida laboratory reports the generation of a platform of human heart organoids derived from iPS cells, which they use to test new therapeutic alternatives on cardiac fibrosis. Their study is published in Frontiers ...
Nov 15, 2022
0
5
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen ...
Nov 10, 2022
0
2
A new approach to stem cell therapy that uses antibodies instead of traditional immunosuppressant drugs robustly preserves cells in mouse brains and has potential to fast-track trials in humans, a Michigan Medicine study ...
Nov 9, 2022
0
19
Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
Nov 9, 2022
0
31
An interdisciplinary research team led by UCLA found that a drug already approved by the Food and Drug Administration for eye disease, verteporfin, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. Their ...
Nov 8, 2022
0
51
Researchers at The University of Queensland have discovered a link between obstructive sleep apnea and an increased risk of developing dementia.
Nov 8, 2022
0
49
Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They ...
Nov 8, 2022
0
61
People with inflammatory bowel diseases develop inflammation of the intestine that can cause thickening of the gut wall and life-threatening blockage of the intestinal tube. Twenty to 50 percent of people with Crohn's disease ...
Nov 7, 2022
0
552
Using human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus that causes COVID-19 ...
Nov 3, 2022
0
70
Researchers from the Epigenetics and Immune Disease Lab at the Josep Carreras Leukaemia Research Institute have recently shown that vitamin C improves the immunogenic properties of dendritic cells in vitro.
Nov 2, 2022
0
5
